Clinuvel Pharmaceuticals Limited

Clinuvel Pharmaceuticals Limitedverified

CLVLF

Price:

$7.54

Market Cap:

$618.03M

Clinuvel Pharmaceuticals Limited, a biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally. Its lead drug candidate is SCENESSE, a systemic photoprotective drug for the prevention of phototoxicity in adult patients with erythropoietic protoporphyria (EPP). The company's pipeline products include CUV9900, an alpha-melanocyte stimulating hormone analogue; Parvysmelanotide (VLRX001), which provoke increased and prolonged cellular activity; and PRÉNUMBRA, a liquid injectable formulation of afamelanotide. Clinuvel Pharmaceuticals L...[Read more]

Industry

Biotechnology

IPO Date

2009-02-13

Stock Exchange

OTC

Ticker

CLVLF

The Enterprise Value as of December 2025 (TTM) for Clinuvel Pharmaceuticals Limited (CLVLF) is 394.46M

According to Clinuvel Pharmaceuticals Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 394.46M. This represents a change of -29.53% compared to the average of 559.76M of the last 4 quarters.

Clinuvel Pharmaceuticals Limited (CLVLF) Historical Enterprise Value (quarterly & annually)

How has CLVLF Enterprise Value performed in the past?

The mean historical Enterprise Value of Clinuvel Pharmaceuticals Limited over the last ten years is 769.79M. The current 394.46M Enterprise Value has changed 5.02% with respect to the historical average. Over the past ten years (40 quarters), CLVLF's Enterprise Value was at its highest in in the June 2019 quarter at 1.54B. The Enterprise Value was at its lowest in in the December 2005 quarter at 0.

Quarterly (TTM)
Annual

Average

769.79M

Median

652.11M

Minimum

181.79M

Maximum

1.54B

Clinuvel Pharmaceuticals Limited (CLVLF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Clinuvel Pharmaceuticals Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 213.91%

Maximum Annual Enterprise Value = 1.54B

Minimum Annual Increase = -52.22%

Minimum Annual Enterprise Value = 181.79M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2025296.21M-50.35%
2024596.62M-30.67%
2023860.59M21.62%
2022707.59M-52.22%
20211.48B19.52%
20201.24B-19.35%
20191.54B213.91%
2018489.45M58.41%
2017308.99M69.97%
2016181.79M61.44%

Clinuvel Pharmaceuticals Limited (CLVLF) Average Enterprise Value

How has CLVLF Enterprise Value performed in the past?

The current Enterprise Value of Clinuvel Pharmaceuticals Limited (CLVLF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

584.47M

5-year avg

788.41M

10-year avg

769.79M

Clinuvel Pharmaceuticals Limited (CLVLF) Enterprise Value vs. Peers

How is CLVLF’s Enterprise Value compared to its peers?

Clinuvel Pharmaceuticals Limited’s Enterprise Value is greater than Frontage Holdings Corporation (372.36M), greater than Immutep Limited (316.92M), less than Northwest Biotherapeutics, Inc. (439.17M), less than CytoDyn Inc. (444.78M), greater than PureTech Health plc (150.89M), greater than Cellectis S.A. (381.74M), less than Healios K.K. (39.39B), greater than hVIVO plc (3.08M), greater than Euroapi S.A. (305.21M), less than Hansa Biopharma AB (publ) (3.50B),

CompanyEnterprise ValueMarket cap
372.36M$303.75M
316.92M$264.95M
439.17M$366.68M
444.78M$410.33M
150.89M$406.03M
381.74M$325.46M
39.39B$344.26M
3.08M$164.93M
305.21M$341.82M
3.50B$246.65M

Build a custom stock screener for Clinuvel Pharmaceuticals Limited (CLVLF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Clinuvel Pharmaceuticals Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Clinuvel Pharmaceuticals Limited (CLVLF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Clinuvel Pharmaceuticals Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Clinuvel Pharmaceuticals Limited's Enterprise Value?

What is the highest Enterprise Value for Clinuvel Pharmaceuticals Limited (CLVLF)?

What is the 3-year average Enterprise Value for Clinuvel Pharmaceuticals Limited (CLVLF)?

What is the 5-year average Enterprise Value for Clinuvel Pharmaceuticals Limited (CLVLF)?

How does the current Enterprise Value for Clinuvel Pharmaceuticals Limited (CLVLF) compare to its historical average?